Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
Clinical trial NCT04361162 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04361162
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-18
- Primary completion
- 2022-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.